Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

BioScience Health Innovations (BHIC) EPS (Weighted Average and Diluted) (2023 - 2025)

Historic EPS (Weighted Average and Diluted) for BioScience Health Innovations (BHIC) over the last 3 years, with Q3 2025 value amounting to -$0.0.

  • BioScience Health Innovations' EPS (Weighted Average and Diluted) fell 10770.41% to -$0.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.01, marking a year-over-year change of 0.0%. This contributed to the annual value of $0.0 for FY2024, which is 12054.12% up from last year.
  • BioScience Health Innovations' EPS (Weighted Average and Diluted) amounted to -$0.0 in Q3 2025, which was down 10770.41% from $0.01 recorded in Q2 2025.
  • In the past 5 years, BioScience Health Innovations' EPS (Weighted Average and Diluted) registered a high of $0.01 during Q3 2024, and its lowest value of -$0.0 during Q3 2023.
  • In the last 3 years, BioScience Health Innovations' EPS (Weighted Average and Diluted) had a median value of $0.0 in 2024 and averaged $0.0.
  • Data for BioScience Health Innovations' EPS (Weighted Average and Diluted) shows a peak YoY increase of 87540.37% (in 2025) and a maximum YoY decrease of 10770.41% (in 2025) over the last 5 years.
  • Quarter analysis of 3 years shows BioScience Health Innovations' EPS (Weighted Average and Diluted) stood at -$0.0 in 2023, then soared by 120.68% to $0.0 in 2024, then plummeted by 427.71% to -$0.0 in 2025.
  • Its last three reported values are -$0.0 in Q3 2025, $0.01 for Q2 2025, and $0.01 during Q1 2025.